Over the past two days, the ASH-FDA Collaboration brought together participants, ASH and FDA leaders, and FDA staff to explore hematology product development through panels, case studies, and discussions on key regulatory issues.
Learn more about the workshop: ow.ly/yApC50ZTc8o
